#aacrMPCD22 Conference Hashtag
AACR Conference on Myeloma and Plasma Cell Dyscrasias
The conference will focus on the areas of disease progression, drug resistance, epigenetics, genomics, immunotherapy, microenvironment, and novel therapeutics. A special session on the future of myeloma clinical trials will include representatives from regulatory agencies, academia, and industry to discuss minimal residual disease, trial endpoints, early/late intervention, and disease maintenance.
Conference Website
